Matches in Wikidata for { <http://www.wikidata.org/entity/Q80407516> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- Q80407516 description "article scientifique publié en 2004" @default.
- Q80407516 description "artículu científicu espublizáu n'ochobre de 2004" @default.
- Q80407516 description "im Oktober 2004 veröffentlichter wissenschaftlicher Artikel" @default.
- Q80407516 description "scientific article published on 01 October 2004" @default.
- Q80407516 description "wetenschappelijk artikel" @default.
- Q80407516 description "наукова стаття, опублікована в жовтні 2004" @default.
- Q80407516 name "Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: a randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working" @default.
- Q80407516 name "Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: a randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working" @default.
- Q80407516 type Item @default.
- Q80407516 label "Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: a randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working" @default.
- Q80407516 label "Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: a randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working" @default.
- Q80407516 prefLabel "Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: a randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working" @default.
- Q80407516 prefLabel "Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: a randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working" @default.
- Q80407516 P1104 Q80407516-6DED30EF-176A-4910-A0FC-F60D66F498FA @default.
- Q80407516 P1433 Q80407516-599163F3-F13E-4E31-A395-3D465ABAFD4F @default.
- Q80407516 P1476 Q80407516-DD77C39F-3FC3-4DE2-A732-23C61B50B29C @default.
- Q80407516 P2093 Q80407516-0E215BC1-6A70-4A2A-9CB2-8EC700052C7A @default.
- Q80407516 P2093 Q80407516-141B4B16-4C61-4800-A5F4-2DFD68656EF7 @default.
- Q80407516 P2093 Q80407516-15016782-572A-45E3-8146-76D3D66020D1 @default.
- Q80407516 P2093 Q80407516-49951559-9E4D-4207-80F3-924678B6AF16 @default.
- Q80407516 P2093 Q80407516-604BA6D2-AFB6-4221-953D-4FBD0389544F @default.
- Q80407516 P2093 Q80407516-6B161E78-AD7D-40CE-9512-EF20913217F9 @default.
- Q80407516 P2093 Q80407516-804C6A50-08E4-4488-BF87-0CC5EAD76331 @default.
- Q80407516 P2093 Q80407516-942C81E0-96D8-4EFC-A05D-DC1DFBF1BC11 @default.
- Q80407516 P2093 Q80407516-C456D67F-79A7-4F34-A5C1-9D80F5E83828 @default.
- Q80407516 P2093 Q80407516-DE87E05A-4920-477B-9107-691557F8BF75 @default.
- Q80407516 P2093 Q80407516-F18731EA-0B47-49C1-B3B2-0985FA0E8EBB @default.
- Q80407516 P2093 Q80407516-F68C7BB5-08A1-4434-84D8-A3E69BF0A0AA @default.
- Q80407516 P304 Q80407516-4284F23E-7C06-4EDC-8167-28CA82C0329E @default.
- Q80407516 P31 Q80407516-F681F730-38D0-4361-94B0-AB9A077D2B12 @default.
- Q80407516 P356 Q80407516-5B47CE49-D278-4E49-B491-A23FEA163B54 @default.
- Q80407516 P433 Q80407516-E7B4A77B-86A1-4877-9766-6C238A376845 @default.
- Q80407516 P478 Q80407516-823ECE4D-180A-49B9-9864-AB4C0EB31F4A @default.
- Q80407516 P50 Q80407516-6873A545-48AA-434D-8A2E-D12ECAACCAD0 @default.
- Q80407516 P50 Q80407516-85E4F47E-18C9-4E91-A284-01D4E5AAD8EC @default.
- Q80407516 P577 Q80407516-3E502304-792D-4A85-8797-2F027AD393E7 @default.
- Q80407516 P698 Q80407516-340DEEF2-323D-43EE-9373-6A094F502F48 @default.
- Q80407516 P921 Q80407516-7529247C-7570-42F1-B08A-F7D4A7DEBF62 @default.
- Q80407516 P921 Q80407516-AE7C21D1-F9C3-472D-B61B-63DBE3B70916 @default.
- Q80407516 P921 Q80407516-F3B9CAE7-A8CD-41D8-B269-23DF1E5FD6F1 @default.
- Q80407516 P356 J.LEUKRES.2004.03.001 @default.
- Q80407516 P698 15289018 @default.
- Q80407516 P1104 "+11" @default.
- Q80407516 P1433 Q15716445 @default.
- Q80407516 P1476 "Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: a randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working Group for adults" @default.
- Q80407516 P2093 "Augustin Ferrant" @default.
- Q80407516 P2093 "Bob Löwenberg" @default.
- Q80407516 P2093 "Eva van den Berg" @default.
- Q80407516 P2093 "Gregor E G Verhoef" @default.
- Q80407516 P2093 "Leo F Verdonck" @default.
- Q80407516 P2093 "Mark H H Kramer" @default.
- Q80407516 P2093 "Monique M C Steijaert" @default.
- Q80407516 P2093 "Peter C Huijgens" @default.
- Q80407516 P2093 "Pierre W Wijermans" @default.
- Q80407516 P2093 "Pieter Sonneveld" @default.
- Q80407516 P2093 "Rien van Marwijk Kooy" @default.
- Q80407516 P2093 "Simon Daenen" @default.
- Q80407516 P304 "1057-1067" @default.
- Q80407516 P31 Q13442814 @default.
- Q80407516 P356 "10.1016/J.LEUKRES.2004.03.001" @default.
- Q80407516 P433 "10" @default.
- Q80407516 P478 "28" @default.
- Q80407516 P50 Q110192041 @default.
- Q80407516 P50 Q89534570 @default.
- Q80407516 P577 "2004-10-01T00:00:00Z" @default.
- Q80407516 P698 "15289018" @default.
- Q80407516 P921 Q367700 @default.
- Q80407516 P921 Q418817 @default.
- Q80407516 P921 Q42824440 @default.